Literature DB >> 8589729

An RNA recognition motif in Wilms' tumour protein (WT1) revealed by structural modelling.

D Kennedy1, T Ramsdale, J Mattick, M Little.   

Abstract

The Wilms' tumour suppressor gene 1 (WT1) (1,2) encodes four C2H2 zinc finger-containing proteins (3) critical for normal mammalian urogenital development (4). Mutations in this gene are observed in the childhood kidney cancer, Wilms' tumour (WT) (5). WT1 can bind specific DNA targets within the promoters of many genes (6-9) and both transcriptional repression and activation domains have been identified (10). On this basis, it has been assumed that regulation of transcription is the basis of WT1 tumour suppressor activity. However, subnuclear localization studies have revealed an association between WT1 proteins and 'speckled bodies' within the nucleus. Degradation of nuclear RNA in cells expressing WT1 abolishes this speckled localization and WT1 co-immunoprecipitates with a number of spliceosomal proteins, suggesting that it may also bind to RNA (11). Using structural rather than sequence comparison, we have now identified an evolutionarily conserved N-terminal RNA recognition motif (RRM) in all known WT1 isoforms similar to that in the constitutive splicing factor U1A. Given the association between WT1 mutations and Wilms' tumours, this study, together with other recent findings, may suggest a novel tumour suppression mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8589729     DOI: 10.1038/ng0396-329

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  21 in total

Review 1.  The possible role and application of WT1 in human leukemia.

Authors:  Z Chen
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

2.  HuR antagonizes the effect of an intronic pyrimidine-rich sequence in regulating WT1 +/-KTS isoforms.

Authors:  Hui Li; Shuai Hou; Tian Hao; Sikandar Azam; Caigang Liu; Lei Shi; Haixin Lei
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

3.  WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes.

Authors:  R C Davies; C Calvio; E Bratt; S H Larsson; A I Lamond; N D Hastie
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

4.  Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation.

Authors:  Y Ye; B Raychaudhuri; A Gurney; C E Campbell; B R Williams
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

5.  Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.

Authors:  Maike Busch; Heinrich Schwindt; Artur Brandt; Manfred Beier; Nicole Görldt; Paul Romaniuk; Eneda Toska; Stefan Roberts; Hans-Dieter Royer; Brigitte Royer-Pokora
Journal:  Hum Mol Genet       Date:  2014-03-11       Impact factor: 6.150

6.  WT1 expression is increased in primary fibroblasts derived from Dupuytren's disease tissues.

Authors:  Justin Crawford; Christina Raykha; Daevina Charles; Bing Siang Gan; David B O'Gorman
Journal:  J Cell Commun Signal       Date:  2015-06-30       Impact factor: 5.782

7.  Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product.

Authors:  N Bardeesy; J Pelletier
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

8.  Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA.

Authors:  E Lalli; K Ohe; C Hindelang; P Sassone-Corsi
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

Review 9.  RNA binding protein sex-lethal (Sxl) and control of Drosophila sex determination and dosage compensation.

Authors:  Luiz O F Penalva; Lucas Sánchez
Journal:  Microbiol Mol Biol Rev       Date:  2003-09       Impact factor: 11.056

10.  Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression.

Authors:  M Nemani; G Linares-Cruz; H Bruzzoni-Giovanelli; J P Roperch; M Tuynder; L Bougueleret; D Cherif; M Medhioub; P Pasturaud; V Alvaro; H der Sarkissan; L Cazes; D Le Paslier; I Le Gall; D Israeli; J Dausset; F Sigaux; I Chumakov; M Oren; F Calvo; R B Amson; D Cohen; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.